Search

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To explore the diagnostic value of alphafetoprotein (AFP), blood rheology, hypersensitive C-reactive protein (hs-CRP) and other indicators in patients with early liver cancer. Methods: 115 patients with liver cancer diagnosed by surgery and pathology who were admitted to our hospital from May 2016 to May 2019 were classified as group A, 109 patients with other benign liver lesions were classified as group B, and 98 healthy patients during the same period of physical examination As the control group C, observe the levels of various indicators such as AFP, hemorheology and hypersensitivity C-reactive protein in the three groups. Results: The levels of AFP and hs-CRP in group A were significantly higher than those in the benign liver disease group in group B and the healthy control group in group C. AFP in group B was higher than that in group C. The difference between the groups was statistically significant (P<0.05). ), there was no significant difference in hs-CRP levels between group B and group C (P>0.05); group A patients had high, medium, and low shear viscosity, whole blood viscosity, hematocrit, hematocrit, and erythrocyte sedimentation rate. The K value of the equation, fibrinogen, erythrocyte aggregation index, and erythrocyte rigidity index were significantly higher than those in groups B and C. The erythrocyte sedimentation rate and erythrocyte sedimentation rate equation K values ​​of patients in group B were significantly higher than those in group C, and the differences between the groups were statistically significant. Significance (P<0.05); The erythrocyte sedimentation rate K value, hematocrit, plasma viscosity and low-shear viscosity of whole blood in patients with liver cancer with higher TNM staging in group A were significantly higher than those with low TNM staging, and the difference was statistically significant ( P<0.05). Conclusion: The abnormal changes of AFP, hs-CRP combined with blood rheological indexes of patients can be used as a basis for distinguishing benign liver diseases and malignant tumors, and at the same time, it can improve the accuracy of diagnosis, and can be used in the clinical scope. [ABSTRACT FROM AUTHOR]

Objective: To explore the changes of glucose metabolism and renal function in patients with gestational hypothyroidism and their clinical significance. Methods: A total of 60 pregnant women with hypothyroidism who visited our hospital from June 2015 to August 2019 were selected as the hypothyroidism group and 60 healthy pregnant women in the same period were selected as the control group. The thyroid function [thyroid-stimulating hormone (TSH), three free iodine thyroid former glycine (FT3) and free thyroxine (FT4)], glucose metabolismindex [(FBG), fasting blood glucose level, glycosylated hemoglobin (HbA1C), 2 h postprandial extract elbow venous blood determination of postprandial glucose level 2h (2 HPG), insulin resistance index (HOMA IR)] and renal function (serum creatinine (Cr), serumuric acid (UA), blood urea nitrogen (BUN)] as well as the pregnancy outcome were compared between two groups of patients and the relationship between thyroid function and metabolism of glucose metabolism and renal function was analyzed. Results: The levels of TSH, glucose metabolismand renal function of pregnant women in the hypothyroidismgroup were significantly higher than those in the control group, and FT4 was significantly lower than those in the control group (P<0.05). TSH was positively correlated with each index of glucose metabolism(P< 0.05). FT4 was negatively correlated with all indicators of glucose metabolism (P< 0.05), FT3 was negatively correlated with Cr (P<0.05), and TSH, FT4 were not significantly correlated with Cr, UA, and BUN (P>0.05). The adverse pregnancy outcome rate of hypothyroidism group was 20.00%, significantly higher than that of control group (6.67%, P<0.05). Conclusion: Patients with hypothyroidism during pregnancy have disorders of glucose metabolismand abnormal renal function, which may lead to adverse pregnancy outcomes. [ABSTRACT FROM AUTHOR]

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)